Literature DB >> 7030005

Calcium blockade as a therapeutic principle in arterial hypertension. Clinical aspects and experimental studies on isolated vessels from spontaneously hypertensive rats and normotensive man.

O L Pedersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030005     DOI: 10.1111/j.1600-0773.1981.tb03365.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  9 in total

Review 1.  Studies on verapamil in the treatment of essential hypertension: a review.

Authors:  K Midtbø; O Hals; O Lauve; J van der Meer; L Storstein
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.

Authors:  V Csik; L Szekeres; E Udvary
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

Review 3.  Isradipine in hypertension.

Authors:  L Hansson
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist.

Authors:  K Lange Andersen; W Piatkowski; K A Green; W Ottmann
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

5.  Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  S E Husted; H K Nielsen; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Hemodynamic effects of Ro 23-6152 in patients with essential hypertension.

Authors:  H B Folkers; J C van Zwienen; P Boer; C H Kleinbloesem; G G Geyskes
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.

Authors:  H E Sluiter
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension.

Authors:  C Gennari; R Nami; G Pavese; S Gragnani; C Bianchini; P Buracchi
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.